SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $209,000 | -2.3% | 5,758 | -4.4% | 0.01% | 0.0% |
| Q4 2022 | $214,000 | +4.9% | 6,021 | -0.4% | 0.01% | -11.1% |
| Q3 2022 | $204,000 | +1.5% | 6,045 | -3.2% | 0.01% | +28.6% |
| Q1 2022 | $201,000 | -38.2% | 6,242 | -47.2% | 0.01% | -36.4% |
| Q3 2019 | $325,000 | -24.4% | 11,815 | -9.1% | 0.01% | -21.4% |
| Q2 2019 | $430,000 | -4.0% | 12,991 | +1.7% | 0.01% | 0.0% |
| Q1 2019 | $448,000 | -33.0% | 12,779 | -36.6% | 0.01% | -39.1% |
| Q4 2018 | $669,000 | -42.4% | 20,144 | -12.7% | 0.02% | -30.3% |
| Q3 2018 | $1,162,000 | +129.2% | 23,086 | +172.5% | 0.03% | +43.5% |
| Q2 2018 | $507,000 | – | 8,471 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |